Work

BET Bromodomain Inhibition Reduces Leukemic Burden and Prolongs Survival In The Eμ-TCL1 Transgenic Mouse Model Of Chronic Lymphocytic Leukemia (CLL) Independent Of TP53 Mutation Status

Year: 2013

Type: article

Source: Blood

DOI: 10.1182/blood.v122.21.876.876

Authors: Connie A Larsson, Kensuke Kojima, Yong Wang, Nicholas Navin, Miguel Gallardo, Daniel Primo, Jose L. Rojas, Joaquin Martinez, Taghi Manshouri, Hun Ju Lee, James E Bradner, Juan Ballesteros, Sean M. Post, Guillermina (Gigi) Lozano, Alfonso Quintás-Cardama

Institutions: The University of Texas MD Anderson Cancer Center, Saga University, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W143166624

FWCI:

Cites:

Cited by:

Related to: 10